PULSE BIOSCIENCES, INC. — Director's Dealing 2017

Aug 4, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2017-08-01

Reporting Person: DUGGAN ROBERT W (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-08-01	Common Stock	P	42990	$20.20	Acquired	3153234	Direct
2017-08-01	Common Stock	P	17010	$20.945	Acquired	3170244	Direct
2017-08-01	Common Stock	P	8000	$22.748	Acquired	3178244	Direct
2017-08-01	Common Stock	P	80618	$23.476	Acquired	3258862	Direct
2017-08-01	Common Stock	P	6868	$24.018	Acquired	3265730	Direct
2017-08-02	Common Stock	P	14710	$24.372	Acquired	3280440	Direct
2017-08-02	Common Stock	P	38290	$25.121	Acquired	3318730	Direct
2017-08-03	Common Stock	P	68964	$23.704	Acquired	3387694	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	35000	Indirect

Footnotes

F1: This is the weighted average purchase price of the shares, which ranged from $19.64 to $20.626 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

F2: This is the weighted average purchase price of the shares, which ranged from $20.646 to $21.64 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

F3: This is the weighted average purchase price of the shares, which ranged from $21.94 to $22.939 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

F4: This is the weighted average purchase price of the shares, which ranged from $22.998 to $23.99 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

F5: This is the weighted average purchase price of the shares, which ranged from $24.00 to $24.05 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

F6: This is the weighted average purchase price of the shares, which ranged from $23.885 to $24.88 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

F7: This is the weighted average purchase price of the shares, which ranged from $24.89 to $25.68 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

F8: This is the weighted average purchase price of the shares, which ranged from $23.121 to $23.916 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

F9: Shares are held by Genius Incorporated, of which the Reporting Person is the sole member and beneficiary.